Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VIPR1 | P32241 | 4/20 | 0.52 |
| ▸ | VIPR2 | P41587 | 6/20 | 0.49 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.47 |
| ▸ | TFPI | P10646 | 1/20 | 0.46 |
| ▸ | ECE1 | P42892 | 1/20 | 0.46 |
| ▸ | GLP1R | P43220 | 1/20 | 0.46 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.46 |
| ▸ | BACE1 | P56817 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31465334 | 0.95 | VIPR1 (0.54) | VIPR1VIPR2RXFP1TFPIECE1 | |
| SCHEMBL29972934 | 0.95 | VIPR1 (0.48) | VIPR1VIPR2RXFP1TFPIBACE1 | |
| SCHEMBL29473709 | 0.91 | VIPR1 (0.46) | VIPR1VIPR2 | |
| SCHEMBL30662325 | 0.90 | VIPR1 (0.58) | VIPR1VIPR2RXFP1TFPIBACE1 | |
| SCHEMBL31257025 | 0.90 | BACE1 (0.49) | VIPR1VIPR2BACE1 | |
| SCHEMBL30483990 | 0.89 | VIPR1 (0.55) | VIPR1VIPR2RXFP1TFPIECE1 | |
| SCHEMBL29473681 | 0.89 | VIPR1 (0.54) | VIPR1VIPR2RXFP1TFPI | |
| SCHEMBL29650465 | 0.89 | VIPR1 (0.52) | VIPR1VIPR2TFPIBACE1 | |
| SCHEMBL29473651 | 0.88 | VIPR1 (0.53) | VIPR1VIPR2RXFP1TFPI | |
| SCHEMBL29965025 | 0.88 | VIPR1 (0.56) | VIPR1VIPR2RXFP1TFPIECE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12622769-B2 | Dental implant container and an implant | Universitiit für Bodenkultur Wien (AT) | 2026-05-12 | — | — | US | disclosed |
| US-20250312127-A1 | IMPROVED DENTAL IMPLANT CONTAINER AND AN IMPLANT | UNIVERSITÄT FÜR BODENKULTUR WIEN (AT) | 2025-10-09 | — | — | US | disclosed |
| US-20250289909-A1 | FUNCTIONALIZED AND CROSSLINKED POLYMERS | PMIDG LLC (US) | 2025-09-18 | — | — | US | disclosed |
| US-12351656-B2 | Functionalized and crosslinked polymers | PMIDG, LLC (US) | 2025-07-08 | — | — | US | disclosed |
| US-20240033283-A1 | FUNCTIONALIZED AND CROSSLINKED POLYMERS | POLY-MED, INC. | 2024-02-01 | — | — | US | disclosed |
| US-20230312764-A1 | FUNCTIONALIZED AND CROSSLINKED POLYMERS | PMIDG LLC (US) | 2023-10-05 | — | — | US | disclosed |
| US-11440976-B2 | Functionalized and crosslinked polymers | PMIDG, LLC (US) | 2022-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12622769-B2 | Dental implant container and an implant | EPCAM, L1CAM, CD63 | VIPR1 4030/4885VIPR2 3815/4885RXFP1 3972/4885 |
| US-20240033283-A1 | FUNCTIONALIZED AND CROSSLINKED POLYMERS | VCL, PARN, PARG | VIPR1 3630/4885VIPR2 3655/4885RXFP1 4461/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.